Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: mike devage who wrote (4297)	10/9/1999 5:47:00 PM
From: DanZ	Read Replies (1) \| Respond to of 10293

Mike, Several companies might be interested in marketing Zicam after the clinical results are made public. This was discussed during a conference call several months ago and the company left its options open. It is reasonable to speculate that they are already lining up a partner to market Zicam in other countries. A complete purchase of the company is more complex because of their gum business. I personally don't think that GumTech is interested in selling themselves and the last thing that a short wants is a hostile takeover of the company. Best regards, Smiling Dan